Ali OVAYOLU, Mucahid YILMAZ, Erhan SARAÇOĞLU, Yusuf ÇEKİCİ, Salih KILIÇ, İrfan Veysel DÜZEN

Evaluation of Tpe-interval and Tpe/QT, Tpe/QTc ratios in patients with premature ovarian failure

Aim: Ventricular repolarization were evaluated in patients who had POF by using novel electrocardiographic parameters includingTpe-interval and Tpe/QT and Tpe/QTc ratios. A few studies have investigated the association between premature ovarian failure(POF) and cardiovascular diseases. However, none have examined ventricular repolarization in this respect.Materials and Methods: This cross-sectional study included 60 female patients with POF (mean 32.6±4.7 years) and 54 controlhealthy female subjects (mean 30.9±4.6 years).All electrocardiogram (ECG) measurements were performed by a cardiologist usinga computer, and the Tpe-interval, Tpe/QT, and Tpe/QTc were compared between groups.Results: There were no significant differences between groups in terms of baseline characteristics and laboratory parameters. TheTpe-interval, Tpe/QT, and Tpe/QTc were significantly prolonged in POF group than control subjects (p

PDF

___

1. Jankowska K. Premature ovarian failure. Przeglad menopauzalny= Menopause review 2017;16:51.
2. Wellons M, Ouyang P, Schreiner PJ, et al. Early menopause predicts future coronary heart disease and stroke: the Multi-Ethnic Study of Atherosclerosis (MESA). Menopause (New York, NY) 2012;19:1081.
3. Sims C, Reisenweber S, Viswanathan PC, et al. Sex, age, and regional differences in L-type calcium current are important determinants of arrhythmia phenotype in rabbit hearts with drug-induced long QT type 2. Circulation research 2008;102:86-100.
4. Canpolat U, Tokgözoğlu L, Yorgun H, et al. The association of premature ovarian failure with ventricular repolarization dynamics evaluated by QT dynamicity. Europace 2013;15:1657-63.
5. Sedlak T, Shufelt C, Iribarren C, et al. Sex hormones and the QT interval: a review. Journal of Women’s Health 2012;21:933-41.
6. Merz CNB, Shaw LJ, Azziz R, et al. Cardiovascular disease and 10-year mortality in postmenopausal women with clinical features of polycystic ovary syndrome. Journal of Women’s Health 2016;25:875- 81.
7. Kurokawa J, Kodama M, Clancy CE, et al. Sex hormonal regulation of cardiac ion channels in druginduced QT syndromes. Pharmacology & therapeutics 2016;168:23-8.
8. Ravens U. Sex differences in cardiac electrophysiology. Canadian journal of physiology and pharmacology. 2018;96:985-90.
9. Opthof T, Janse MJ, Meijborg VM, et al. Dispersion in ventricular repolarization in the human, canine and porcine heart. Progress in biophysics and molecular biology. 2016;120:222-35.
10. Srinivasan NT, Orini M, Simon RB, et al. Ventricular stimulus site influences dynamic dispersion of repolarization in the intact human heart. American Journal of Physiology-Heart and Circulatory Physiology. 2016;311:545-54.
11. Porthan K, Viitasalo M, Toivonen L, et al. Predictive Value of Electrocardiographic T-Wave Morphology Parameters and T-Wave Peak to T-Wave End Interval for Sudden Cardiac Death in the General PopulationClinical Perspective. Circulation: Arrhythmia and Electrophysiology. 2013;6:690-6.
12. Prenner SB, Shah SJ, Goldberger JJ, et al. Repolarization heterogeneity: beyond the QT interval. Journal of the American Heart Association 2016;5:003607.
13. Dressler F, Brado J, Odening K. Electromechanical heterogeneity in the heart. Herzschrittmachertherapie Elektrophysiologie 2018;29:43-7.
14. 14. Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification. European journal of echocardiography 2006;7:79-108.
15. 15. Chua KC, Rusinaru C, Reinier K, et al. Tpeak-toTend interval corrected for heart rate: A more precise measure of increased sudden death risk? Heart rhythm 2016;13:2181-5.
16. 16. Qu Z, Weiss JN. Mechanisms of ventricular arrhythmias: from molecular fluctuations to electrical turbulence. Annual review of physiology 2015;77:29- 55.
17. 17. Antzelevitch C. Tpeak–Tend interval as an index of transmural dispersion of repolarization. European journal of clinical investigation. 2001;31:555-7.
18. 18. Tse G, Gong M, Wong WT, et al. The Tpeak− Tend interval as an electrocardiographic risk marker of arrhythmic and mortality outcomes: A systematic review and meta-analysis. Heart Rhythm 2017;14:1131-7.
19. 19. Erikssen G, Liestøl K, Gullestad L, et al. The terminal part of the QT interval (T peak to T end): a predictor of mortality after acute myocardial infarction. Annals of Noninvasive Electrocardiology 2012;17:85-94.
20. 20. Zhao X, Xie Z, Chu Y, et al. Association Between Tpe/QT Ratio and Prognosis in Patients Undergoing Primary Percutaneous Coronary Intervention for STSegment Elevation Myocardial Infarction. Clinical cardiology 2012;35:559-64.
21. 21. Wellons M, editor Cardiovascular disease and primary ovarian insufficiency. Seminars in reproductive medicine 2011: NIH Public Access.
22. 22. Muka T, Oliver-Williams C, Kunutsor S, et al. Association of age at onset of menopause and time since onset of menopause with cardiovascular outcomes, intermediate vascular traits, and all-cause mortality: a systematic review and meta-analysis. JAMA cardiology 2016;1:767-76.
23. 23. Legato MJ, Johnson PA, Manson JE. Consideration of sex differences in medicine to improve health care and patient outcomes. Jama 2016;316:1865-6.
24. 24. EUGenMed, Group CCS, Regitz-Zagrosek V, et al. Gender in cardiovascular diseases: impact on clinical manifestations, management, and outcomes. European heart journal 2015;37:24-34.
25. 25. Bazett HC. An analysis of the time relations of electrocardiograms. Heart 1920;7:353-70. 26. 26. Philp K, Hussain M, Byrne N, et al. Greater antiarrhythmic activity of acute 17βestradiol in female than male anaesthetized rats: correlation with Ca2+ channel blockade. British journal of pharmacology 2006;149:233-42.
27. 27. Jiang H, Hu X, Wang J. Estrogen replacement therapy for idiopathic outflow tract ventricular arrhythmias: A potential therapeutic approach. Medical hypotheses.2012;78:144-5.
28. 28. Larsen JA, Tung RH, Sadananda R, Goldberger JJ, Horvath G, Parker MA, et al. Effects of hormone replacement therapy on QT interval. The American journal of cardiology. 1998;82(8):993-5.
29. 29. Tisdale JE, Jaynes HA, Overholser BR, et al. Influence of oral progesterone administration on drug-induced qt interval lengthening: a randomized, double-blind, placebo-controlled crossover study. JACC: Clinical Electrophysiology 2016;2:765-74.
30. 30. Yildirir A, Aybar F, Kabakci MG, et al. Hormone replacement therapy shortens QT dispersion in healthy postmenopausal women. Annals of noninvasive electrocardiology 2001;6:193-7.